Zicthus Therapeutics Salt Lake City, UT - 84108

Zicthus Therapeutics is categorized under Therapeutic X-Ray Apparatus and Tubes in Salt Lake City, UT and active since 2005.

Zicthus Therapeutics was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Therapeutic X-Ray Apparatus and Tubes business, which does work in the B2B market, and is classified as a Therapeutic X-Ray Apparatus and Tubes, under code number 334517 by the NAICS.

If you are seeking more information, feel free to contact David A Jones at the company’s single location by writing to 419 South Wakara Way # 207d, Salt Lake City, Utah UT 84108 or by phoning (801) 450-0089. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Zicthus Therapeutics
Contact Person: David A Jones
Address: 419 South Wakara Way # 207d, Salt Lake City, Utah 84108
Phone Number: (801) 450-0089
Annual Revenue (USD): $100.000 to $499.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Therapeutic X-Ray Apparatus and Tubes
SIC Code: 3844
NAICS Code: 334517
Share This Business:

Zicthus Therapeutics was started in 2005 to provide professional Therapeutic X-Ray Apparatus and Tubes under the SIC code 3844 and NAICS code 334517. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact David A Jones for inquiries that concern Zicthus Therapeutics by calling the company number (801) 450-0089, as your correspondence is most welcome. Additionally, the physical location of the single location of Zicthus Therapeutics can be found at the coordinates 40.760652,-111.827267 as well as the street address 419 South Wakara Way # 207d in Salt Lake City, Utah 84108.

For its online presence, you may visit Zicthus Therapeutics’s website at and engage with its social media outlets through on Twitter and on Facebook.